The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is a common liver disease characterized by excess lipid deposition in the hepatic tissue and subsequent oxidative and inflammatory damage. Curcumin is a dietary polyphenol with lipid-modifying, antioxidant and anti-inflammatory properties. This study aimed to evaluate the efficacy and safety of supplementation with phytosomal curcumin in subjects with NAFLD. Patients diagnosed with NAFLD (grades 1–3 according to liver ultrasonography) were randomly assigned to the curcumin (phytosomal form; 1 000 mg/day in 2 divided doses) (n=50) or placebo group (n=52) for a period of 8 weeks. All patients received dietary and lifestyle advises before the start of trial. Anthropometric measurements, hepatic enzymes, and liver ultrasonography were assessed at baseline and after 8 weeks of follow-up. 87 subjects (n=44 and 43 in the curcumin and control group, respectively) completed the trial. Supplementation with curcumin was associated with a reduction in body mass index (−0.99±1.25 vs. − 0.15±1.31 in the curcumin and placebo groups, respectively; p=0.003) and waist circumference (−1.74±2.58 vs. −0.23±3.49 in the curcumin and placebo groups, respectively; p=0.024). Ultrasonographic findings were improved in 75.0% of subjects in the curcumin group, while the rate of improvement in the control group was 4.7% (p<0.001). Serum levels of aspartate aminotransferase and alanine aminotransferase were reduced by the end of trial in the curcumin group (p<0.001) but elevated in the control group (p<0.001). Curcumin was safe and well tolerated during the course of trial. Short-term supplementation with curcumin improves liver fat and transaminase levels in patients with NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Rao, C. V., Rivenson, A., Simi, B., & Reddy, B. S. (1995) · PubMed · Cited by 676
Huang, M., Lysz, T. W., Ferraro, T., Abidi, T. F., Laskin, D. L., & Conney, A. H. (1991) · PubMed · Cited by 644
Curcumin Extract for Prevention of Type 2 Diabetes
Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., & Jirawatnotai, S. (2012) · Diabetes Care · doi:10.2337/dc12-0116 · Cited by 635
Pathology of nonalcoholic fatty liver disease
Brunt, E. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.21 · Cited by 484
Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals
Aggarwal, B. B. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104755 · Cited by 471
Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M., & Sahebkar, A. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.12.019 · Cited by 406
Self-citationCurcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
Williamson, R. M., Price, J. F., Glancy, S., Perry, E., Nee, L. D., Hayes, P. C., Frier, B. M., Van Look, L. A. F., Johnston, G. I., Reynolds, R. M., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2229 · Cited by 391
Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Simental-Mendía, L. E., Majeed, M., & Sahebkar, A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.05.037 · Cited by 328
Self-citationCurcuminoid Treatment for Knee Osteoarthritis: A Randomized Double‐Blind Placebo‐Controlled Trial
Panahi, Y., Rahimnia, A., Sharafi, M., Alishiri, G., Saburi, A., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5174 · Cited by 310
Self-citationSahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5045 · Cited by 303
Self-citationSahebkar, A., Cicero, A. F. G., Simental-Mendía, L. E., Aggarwal, B. B., & Gupta, S. C. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.026 · Cited by 291
Self-citationSoni, K. B., & Kuttan, R. (1992) · PubMed · Cited by 278
Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., Khojasteh, R., Ghayour‐Mobarhan, M., & Ferns, G. A. (2013) · Phytotherapy Research · doi:10.1002/ptr.4715 · Cited by 277
Self-citationNa, L., Li, Y., Pan, H., Zhou, X., Sun, D., Meng, M., Li, X., & Sun, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200131 · Cited by 269
Semalty, A., Semalty, M., Rawat, M. S. M., & Franceschi, F. (2010) · Fitoterapia · doi:10.1016/j.fitote.2009.11.001 · Cited by 242
Panahi, Y., Khalili, N., Hosseini, M. S., Abbasinazari, M., & Sahebkar, A. (2014) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2014.07.006 · Cited by 231
Self-citationEffects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver
Oetari, S., Sudibyo, M., Commandeur, J. N. M., Samhoedi, R., & Vermeulen, N. P. E. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02113-2 · Cited by 228
Panahi, Y., Alishiri, G. H., Parvin, S., & Sahebkar, A. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2015.1008611 · Cited by 227
Self-citationCurcumin as a MicroRNA Regulator in Cancer: A Review
Momtazi, A. A., Shahabipour, F., Khatibi, S., Johnston, T. P., Pirro, M., & Sahebkar, A. (2016) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_2016_3 · Cited by 226
Self-citationCurcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
Leclercq, I. A., Farrell, G. C., Sempoux, C., Peña, A. D., & Horsmans, Y. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.010 · Cited by 224
Nanji, A. A., Jokelainen, K., Rahemtulla, A., Miao, L., Fogt, F., Matsumoto, H., Tahan, S. R., & Su, G. L. (1999) · Hepatology · doi:10.1002/hep.510300402 · Cited by 216
Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5149 · Cited by 204
Self-citationCurcumin as a natural regulator of monocyte chemoattractant protein-1
Karimian, M. S., Pirro, M., Majeed, M., & Sahebkar, A. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.001 · Cited by 196
Self-citationEsmaily, H., Sahebkar, A., Iranshahi, M., Ganjali, S., Mohammadi, A., Ferns, G., & Ghayour-Mobarhan, M. (2015) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-015-2160-z · Cited by 192
Self-citationCurcumin and Liver Disease: from Chemistry to Medicine
Nabavi, S. F., Daglia, M., Moghaddam, A. H., Habtemariam, S., & Nabavi, S. M. (2014) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12047 · Cited by 192
Panahi, Y., Ghanei, M., Hajhashemi, A., & Sahebkar, A. (2016) · Journal of Dietary Supplements · doi:10.3109/19390211.2014.952865 · Cited by 192
Self-citationCurcumin: An Effective Inhibitor of Interleukin-6
Ghandadi, M., & Sahebkar, A. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161006151605 · Cited by 192
Self-citationPanahi, Y., Badeli, R., Karami, G., & Sahebkar, A. (2015) · Phytotherapy Research · doi:10.1002/ptr.5211 · Cited by 186
Self-citationSahebkar, A., Mohammadi, A., Atabati, A., Rahiman, S., Tavallaie, S., Iranshahi, M., Akhlaghi, S., Ferns, G. A., & Ghayour‐Mobarhan, M. (2013) · Phytotherapy Research · doi:10.1002/ptr.4952 · Cited by 183
Self-citationRole of diet and lifestyle changes in nonalcoholic fatty liver disease.
Nseir, W., Hellou, E., & Assy, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9338 · Cited by 180
Osawa, H., & Mori, Y. (1996) · Journal of Clinical Ultrasound · doi:10.1002/(sici)1097-0096(199601)24:1<25::aid-jcu4>3.0.co;2-n · Cited by 178
Panahi, Y., Sahebkar, A., Parvin, S., & Saadat, A. (2012) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012040 · Cited by 176
Self-citationBradford, P. G. (2013) · BioFactors · doi:10.1002/biof.1074 · Cited by 175
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup
Puri, P., & Sanyal, A. J. (2012) · Clinical Liver Disease · doi:10.1002/cld.81 · Cited by 174
Panahi, Y., Sahebkar, A., Amiri, M., Davoudi, S. M., Beiraghdar, F., Hoseininejad, S. L., & Kolivand, M. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511006544 · Cited by 173
Self-citationCurcuminoids for the management of hypertriglyceridaemia
Sahebkar, A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.140-c1 · Cited by 172
Self-citationSahebkar, A. (2013) · BioFactors · doi:10.1002/biof.1062 · Cited by 170
Self-citationHasan, S. T., Zingg, J.-M., Kwan, P., Noble, T., Smith, D., & Meydani, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.016 · Cited by 166
Recent advances in pharmacotherapy for hypertriglyceridemia
Sahebkar, A., Chew, G. T., & Watts, G. F. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.07.002 · Cited by 164
Self-citationPanahi, Y., Ghanei, M., Bashiri, S., Hajihashemi, A., & Sahebkar, A. (2014) · Drug Research · doi:10.1055/s-0034-1389986 · Cited by 158
Self-citationEffect of Curcumin Supplementation on Physiological Fatigue and Physical Performance in Mice
Huang, W.-C., Chiu, W., Chuang, H.-L., Tang, D., Lee, Z., Li, W., Chen, F., & Huang, C. (2015) · Nutrients · doi:10.3390/nu7020905 · Cited by 155
Curcumin Attenuates Diet‐Induced Hepatic Steatosis by Activating AMP ‐Activated Protein Kinase
Um, M. Y., Hwang, K. H., Ahn, J., & Ha, T. Y. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12076 · Cited by 133
Hepatic steatosis and type 2 diabetes mellitus
Clark, J. M., & Diehl, A. M. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0085-3 · Cited by 117
Curcumin limits the fibrogenic evolution of experimental steatohepatitis
Vizzutti, F., Provenzano, A., Galastri, S., Milani, S., Delogu, W., Novo, E., Caligiuri, A., Zamara, E., Arena, U., Laffi, G., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.112 · Cited by 115
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Burke, A. M. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70435-5 · Cited by 104
Tang, Y., Zheng, S., & Chen, A. (2009) · Endocrinology · doi:10.1210/en.2008-1601 · Cited by 95
Zabihi, N. A., Pirro, M., Johnston, T. P., & Sahebkar, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161010115235 · Cited by 85
Self-citationCurcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-α
Ramírez-Tortosa, M. C., Ramírez-Tortosa, C. L., Mesa, M. D., Granados-Principal, S. M., Gil, Á., & Quiles, J. L. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.015 · Cited by 82
Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro
Kang, H., Nan, J., Park, P., Kim, J., Lee, S. H., Woo, S. W., Zhao, Y., Park, E., & Sohn, D. H. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021771823 · Cited by 80
Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet
Öner-İyidoğan, Y., Koçak, H., Seyithanoğlu, M., Gürdöl, F., Gülçubuk, A., Yıldırım, F., Çevik, A., & Uysal, M. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0244-9 · Cited by 79
Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease?
Finelli, C., & Tarantino, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i46.6790 · Cited by 64
Adjunctive Therapy with Curcumin for Peptic Ulcer: a Randomized Controlled Trial
Khonche, A., Biglarian, O., Panahi, Y., Valizadegan, G., Soflaei, S., Ghamarchehreh, M., Majeed, M., & Sahebkar, A. (2016) · Drug Research · doi:10.1055/s-0042-109394 · Cited by 55
Self-citationWang, Y., Li, J., Zhuge, L., SU, D., Mei-juan, Y., TAO, S., & Li, J. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1461 · Cited by 40
Histological assessment of nonalcoholic fatty liver disease in adults and children
Brunt, E. M. (2012) · Clinical Liver Disease · doi:10.1002/cld.31 · Cited by 36
Low‐Density Lipoprotein is a Potential Target for Curcumin: Novel Mechanistic Insights
Sahebkar, A. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12212 · Cited by 31
Self-citationGut flora-based therapy in liver disease? The liver cares about the gut
Solga, S. F., & Diehl, A. M. (2004) · Hepatology · doi:10.1002/hep.20220 · Cited by 27
Cited by
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“Nevertheless, absent histological evaluation of changes following curcumin treatment strongly limits impact of the studies especially in terms of their anti-fibrotic capacity [379,380].”
BackgroundFarzaei, M. H., Zobeiri, M., Parvizi, F., El-Senduny, F. F., Marmouzi, I., Coy-Barrera, E., Naseri, R., Nabavi, S. M., Rahimi, R., & Abdollahi, M. (2018) · Nutrients · doi:10.3390/nu10070855 · Cited by 485
Immune modulation by curcumin: The role of interleukin-10
Mollazadeh, H., Cicero, A. F. G., Blesso, C. N., Pirro, M., Majeed, M., & Sahebkar, A. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1358139 · Cited by 381
Self-citationMechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
Mortezaee, K., Salehi, E., Mirtavoos‐mahyari, H., Motevaseli, E., Najafi, M., Farhood, B., Rosengren, R. J., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28122 · Cited by 340
Self-citationCurcumin: an inflammasome silencer
Hasanzadeh, S., Read, M. I., Bland, A. R., Majeed, M., Jamialahmadi, T., & Sahebkar, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104921 · Cited by 327
Self-citation
Metadata
- Authors
- Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental-Mendía, L., & Sahebkar, A.
- Venue
- Drug Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017-02-03
- Volume
- 67
- Issue
- 04
- Pages
- 244-251
- ISSN
- 2194-9379 (ISSN-L)
- 2194-9387
- OpenAlex
- W2585491869
- Cited by
- 286
- References
- 68
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.